Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for TWST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 84.96M
March 31, 2026 85.40M
December 31, 2025 85.81M
September 30, 2025 61.75M
June 30, 2025 62.65M
March 31, 2025 65.08M
December 31, 2024 67.59M
September 30, 2024 70.22M
June 30, 2024 72.62M
March 31, 2024 74.80M
December 31, 2023 77.07M
September 30, 2023 79.17M
June 30, 2023 79.90M
March 31, 2023 77.82M
December 31, 2022 79.75M
September 30, 2022 81.27M
June 30, 2022 64.24M
March 31, 2022 65.50M
December 31, 2021 60.28M
September 30, 2021 54.71M
Date Value
June 30, 2021 56.21M
March 31, 2021 25.41M
December 31, 2020 27.64M
September 30, 2020 29.57M
June 30, 2020 31.25M
March 31, 2020 32.70M
December 31, 2019 34.54M
September 30, 2019 7.733M
June 30, 2019 8.452M
March 31, 2019 9.161M
December 31, 2018 9.859M
September 30, 2018 9.718M
June 30, 2018 9.535M
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 9.154M
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Beam Therapeutics, Inc. 232.15M
Intellia Therapeutics, Inc. 50.07M
Prime Medicine, Inc. 103.51M
Absci Corp. 1.792M
10X Genomics, Inc. 66.78M